🧠 Watchlist Winners: Copy Legendary Investors' Portfolios in One ClickCOPY FOR FREE

Dynavax Technologies Corporation (DVAX)

NASDAQ
Currency in USD
Disclaimer
11.170
+0.200(+1.82%)
Closed
After Hours
10.990-0.180(-1.611%)
DVAX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
10.94011.285
52 wk Range
9.74015.150
Prev. Close
10.97
Open
10.94
Day's Range
10.94-11.285
52 wk Range
9.74-15.15
Volume
2,259,049
Average Volume (3m)
2,238,822
1-Year Change
-18.17%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
DVAX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
24.600
Upside
+120.233%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

Dynavax Technologies Corporation Company Profile

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.

Compare DVAX to Peers and Sector

Metrics to compare
DVAX
Peers
Sector
Relationship
P/E Ratio
85.2x−1.1x−0.6x
PEG Ratio
−1.010.000.00
Price/Book
2.3x2.2x2.6x
Price / LTM Sales
5.9x2.1x3.1x
Upside (Analyst Target)
123.8%49.4%55.7%
Fair Value Upside
Unlock22.8%6.8%Unlock

FAQ

What Is the Dynavax (DVAX) Stock Price Today?

The Dynavax stock price today is 11.17.

What Stock Exchange Does Dynavax Trade On?

Dynavax is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Dynavax?

The stock symbol for Dynavax is "DVAX."

What Is the Dynavax Market Cap?

As of today, Dynavax market cap is 1.46B.

What is Dynavax Earnings Per Share?

The Dynavax EPS is 0.132.

What Is the Next Dynavax Earnings Date?

Dynavax will release its next earnings report on 30 Oct 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.